EP0802777A1 - Self-adhesive laminate - Google Patents
Self-adhesive laminateInfo
- Publication number
- EP0802777A1 EP0802777A1 EP96900147A EP96900147A EP0802777A1 EP 0802777 A1 EP0802777 A1 EP 0802777A1 EP 96900147 A EP96900147 A EP 96900147A EP 96900147 A EP96900147 A EP 96900147A EP 0802777 A1 EP0802777 A1 EP 0802777A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- sheet
- laminate
- carrier
- tab
- holding portion
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 239000000853 adhesive Substances 0.000 title abstract description 11
- 239000003814 drug Substances 0.000 claims abstract description 10
- 229940124597 therapeutic agent Drugs 0.000 claims abstract description 4
- 239000000463 material Substances 0.000 claims description 12
- 230000002745 absorbent Effects 0.000 claims description 4
- 239000002250 absorbent Substances 0.000 claims description 4
- 238000000034 method Methods 0.000 claims description 4
- 238000004519 manufacturing process Methods 0.000 claims description 3
- 229920006264 polyurethane film Polymers 0.000 abstract description 9
- 230000001070 adhesive effect Effects 0.000 abstract description 8
- 206010052428 Wound Diseases 0.000 description 27
- 208000027418 Wounds and injury Diseases 0.000 description 27
- 239000010410 layer Substances 0.000 description 11
- 239000012790 adhesive layer Substances 0.000 description 8
- -1 polypropylene Polymers 0.000 description 5
- 235000010443 alginic acid Nutrition 0.000 description 4
- 229920000615 alginic acid Polymers 0.000 description 4
- 229920002635 polyurethane Polymers 0.000 description 4
- 239000004814 polyurethane Substances 0.000 description 4
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 description 3
- 239000004743 Polypropylene Substances 0.000 description 3
- 239000004820 Pressure-sensitive adhesive Substances 0.000 description 3
- 229940072056 alginate Drugs 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 230000035876 healing Effects 0.000 description 3
- 229920001155 polypropylene Polymers 0.000 description 3
- 239000004480 active ingredient Substances 0.000 description 2
- 238000005520 cutting process Methods 0.000 description 2
- 229940100890 silver compound Drugs 0.000 description 2
- 150000003379 silver compounds Chemical class 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- SNICXCGAKADSCV-JTQLQIEISA-N (-)-Nicotine Chemical compound CN1CCC[C@H]1C1=CC=CN=C1 SNICXCGAKADSCV-JTQLQIEISA-N 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 1
- 239000003522 acrylic cement Substances 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000002421 anti-septic effect Effects 0.000 description 1
- 230000003385 bacteriostatic effect Effects 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 239000000356 contaminant Substances 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 238000013270 controlled release Methods 0.000 description 1
- 238000010030 laminating Methods 0.000 description 1
- 238000003475 lamination Methods 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 229960002715 nicotine Drugs 0.000 description 1
- SNICXCGAKADSCV-UHFFFAOYSA-N nicotine Natural products CN1CCCC1C1=CC=CN=C1 SNICXCGAKADSCV-UHFFFAOYSA-N 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920000139 polyethylene terephthalate Polymers 0.000 description 1
- 239000005020 polyethylene terephthalate Substances 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 229920006254 polymer film Polymers 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 230000034918 positive regulation of cell growth Effects 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 150000003378 silver Chemical class 0.000 description 1
- 229910052709 silver Inorganic materials 0.000 description 1
- 239000004332 silver Substances 0.000 description 1
- FJOLTQXXWSRAIX-UHFFFAOYSA-K silver phosphate Chemical compound [Ag+].[Ag+].[Ag+].[O-]P([O-])([O-])=O FJOLTQXXWSRAIX-UHFFFAOYSA-K 0.000 description 1
- NTHWMYGWWRZVTN-UHFFFAOYSA-N sodium silicate Chemical compound [Na+].[Na+].[O-][Si]([O-])=O NTHWMYGWWRZVTN-UHFFFAOYSA-N 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 238000011179 visual inspection Methods 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F13/02—Adhesive bandages or dressings
- A61F13/023—Adhesive bandages or dressings wound covering film layers without a fluid retention layer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F2013/00089—Wound bandages
- A61F2013/00153—Wound bandages coloured or with decoration pattern or printing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F2013/00361—Plasters
- A61F2013/00365—Plasters use
- A61F2013/00519—Plasters use for treating burn
- A61F2013/00523—Plasters use for treating burn with hydrogel
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F2013/00361—Plasters
- A61F2013/00727—Plasters means for wound humidity control
- A61F2013/00731—Plasters means for wound humidity control with absorbing pads
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F2013/00361—Plasters
- A61F2013/00727—Plasters means for wound humidity control
- A61F2013/00748—Plasters means for wound humidity control with hydrocolloids or superabsorbers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F2013/00361—Plasters
- A61F2013/00795—Plasters special helping devices
- A61F2013/008—Plasters special helping devices easy removing of the protection sheet
- A61F2013/00804—Plasters special helping devices easy removing of the protection sheet different adhesion of different adhesive layers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F2013/00361—Plasters
- A61F2013/00795—Plasters special helping devices
- A61F2013/00817—Plasters special helping devices handles or handling tabs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F2013/00361—Plasters
- A61F2013/00795—Plasters special helping devices
- A61F2013/00829—Plasters special helping devices rigid or semi-rigid backing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F2013/00361—Plasters
- A61F2013/00846—Plasters with transparent or translucent part
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F2013/00361—Plasters
- A61F2013/00855—Plasters pervious to air or vapours
- A61F2013/00863—Plasters pervious to air or vapours with pores
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F2013/00361—Plasters
- A61F2013/00855—Plasters pervious to air or vapours
- A61F2013/00868—Plasters pervious to air or vapours thin film
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F2013/00361—Plasters
- A61F2013/00902—Plasters containing means
- A61F2013/00906—Plasters containing means for transcutaneous or transdermal drugs application
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F2013/00361—Plasters
- A61F2013/00902—Plasters containing means
- A61F2013/0091—Plasters containing means with disinfecting or anaesthetics means, e.g. anti-mycrobic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F2013/00361—Plasters
- A61F2013/00902—Plasters containing means
- A61F2013/00927—Plasters containing means with biological activity, e.g. enzymes for debriding wounds or others, collagen or growth factors
Definitions
- This invention relates to a laminate, and relates particularly but not exclusively to a dressing which is self-adherent to body surfaces around a wound.
- laminates for use as wound dressings have become available which are based on plastics films, commonly polyurethane films.
- the film may contain or act as a carrier for substances which act as bacteriostats or promote healing, for example, silver salts or alginates.
- Film dressings of this nature have considerable advantages. Firstly, they can readily be produced in transparent form and thus allow the condition of a wound to be monitored without removing the dressing. Secondly, they can be produced in micro-porous forms which allow movement of water vapour to the exterior of the dressing and movement of air to the interior of the dressing while preventing movement of bacteria through the dressing; this is of particular benefit in treating exuding wounds such as burns.
- a disadvantage associated with known film dressings has been that they can be difficult to apply to a wound. It is usual for a film dressing to have an adhesive layer for application to the skin of a user, the adhesive layer being initially covered by a release paper. Once the release paper is removed from the adhesive layer, the film is delicate and difficult to handle. Stretching of the film can destroy its barrier integrity, whilst a lack of tension during application can lead to wrinkling. For these reasons, most film dressings currently used are provided with a stiffening edge or frame on the outer face, which stiffening must be removed after the dressing has been applied. Known arrangements of dressings can, however, be undesirably complex to apply to a wound or other desired area.
- the present invention provides a laminate having an associated holding portion, the laminate comprising a carrier sheet sandwiched between a removable cover sheet and a removable backing sheet, the laminate further comprising a cover sheet tab attached to the cover sheet and extending away from the carrier sheet, a backing sheet tab attached to the backing sheet and extending away from the carrier sheet and wherein the holding portion is releasably connected to the carrier sheet and is positioned so that it extends along a substantially central portion of one edge of the laminate.
- the laminate may be provided as a dressing, for example, a wound dressing, or a dressing intended to release a medicament or therapeutic agent.
- the laminate may be suitable as a medium for administration of an active ingredient in a controlled release manner over a relatively long period of time (eg several days to weeks) .
- the active ingredient will normally be suitable for transdermal administration.
- the cover sheet tab and backing sheet tab preferably facilitate removal of the cover sheet and backing sheet respectively from the laminate to facilitate application of the laminate to a wound or other area.
- the holding portion is preferably attached to the laminate at a substantially central portion of the edge at which it is positioned and/or on each side of that substantially central portion.
- the holding portion extends substantially along one edge of the laminate.
- the holding portion may be attached to the carrier sheet by means of one or more lines of weakness which may be provided by perforations.
- the holding portion may be a continuation of the laminate.
- the carrier sheet may be formed of a polymeric film material.
- the carrier sheet is substantially porous to vapour and air but is substantially impermeable to particles of dirt or other contaminants, to micro-organisms and pathogens; the carrier sheet may be comprised wholly or partially of polyurethane or of compositions containing polyurethane.
- the carrier sheet may comprise (for example be impregnated or coated with) a medicament or a therapeutic agent (for example, an antibiotic antiseptic, antibacterial, a bacteriostat) , a substance which is intended to promote healing (for example by stimulation of cell growth) or by an absorbent.
- a medicament or a therapeutic agent for example, an antibiotic antiseptic, antibacterial, a bacteriostat
- the carrier sheet may be impregnated with a silver compound or an alginate.
- the carrier sheet may be provided with an absorbent island, for example an alginate pad, which may cover the area to be treated.
- a surface of the carrier sheet may be wholly or partially coated with a pressure sensitive adhesive to facilitate its attachment and retention to the area to be treated.
- the pressure sensitive adhesive may be a skin friendly acrylic adhesive.
- the cover sheet tab may be provided by a tab secured to the cover sheet.
- the cover sheet tab is preferably positioned at the laminate adjacent to the holding portion.
- the cover sheet tab may extend across the width of the laminate and may be of a similar length to the holding portion.
- Positioning the cover sheet tab adjacent to the holding portion may facilitate removal of the cover sheet from the laminate in use.
- the holding portion can be held by the user in one hand and the cover sheet tab is pulled away from the holding portion (thus removing the cover sheet from the laminate) by the user using his or her other hand.
- the backing sheet tab may be provided as an extension of the backing sheet; it may extend beyond a periphery of the carrier layer of the laminate.
- the backing sheet tab may extend substantially along one edge of the laminate.
- the backing sheet tab extends along a side of the laminate which is opposite the holding portion.
- the backing sheet tab may be formed of a flexible tape, for example a polypropylene tape; other self-adhesive pressure sensitive tapes are also suitable.
- the backing sheet may be secured to the laminate by means of adhesion between the material of the backing sheet and the material of the carrier sheet; alternatively, it may be held on the carrier sheet by a separate adhesive material.
- the backing sheet is preferably affixed to the rear face of the carrier sheet with an adhesiveness which is less than the adhesiveness between the front face of the carrier sheet and the cover sheet or, when the laminate has been affixed to a surface, between the carrier sheet and the surface (for example, where the laminate is a dressing the surface will be the wound to which it is applied) .
- the backing sheet may have instructions for use of the laminate printed on it; it may have a pattern printed on it.
- One or more of the carrier sheet, the cover sheet and the backing sheet may be translucent or substantially transparent; this may facilitate visual alignment of the laminate over a wound site when it is to be applied. Where the carrier sheet is substantially transparent, this may facilitate visual inspection of a wound covered by the laminate, when the laminate is in the form of a dressing, without necessitating removal of the dressing from the wound.
- the cover sheet tab and/or the backing sheet tab may be coloured and/or have a pattern and/or indications printed on it to identify the tab region to a user.
- the present invention provides a method of applying a laminate in accordance with the first aspect of the invention, in which: a) a user grips the holding portion in one hand and removes the cover sheet from the laminate by holding the cover sheet tab and pulling the cover sheet tab away from the holding portion to detach the cover sheet from the carrier sheet; b) the exposed surface of the carrier sheet is then applied over a wound or other desired area using the holding portion to grip and position the dressing; c) the backing sheet is removed from the laminate by gripping the backing sheet tab and pulling the backing sheet tab away from the carrier layer to detach the backing sheet from the carrier sheet; and d) the holding portion is then removed from the positioned carrier sheet.
- the present invention provides a method of manufacturing a laminate in accordance with the first aspect of the invention, said method comprising the following steps: a) providing a laminate having a carrier sheet sandwiched between a cover sheet and a backing sheet; b) forming a backing sheet tab; c) forming a cover sheet tab; and d) providing said carrier sheet with an associated holding portion.
- Fig. 1 is a plan view of a first embodiment of a laminate in the form of a wound dressing embodying the present invention, prior to use of the dressing;
- Fig. 2 is a cross-section of Fig. 1;
- Fig. 3 is a cross-section of a second embodiment of a laminate in the form of a wound dressing embodying the present invention;
- Fig. 4 is a cross-section of a third embodiment of a laminate in the form of a wound dressing embodying the present invention;
- Fig. 5 is a cross-section of a fourth embodiment of a wound dressing embodying the present invention.
- the laminate of the dressing 1 shown in Fig 1 comprises a carrier sheet 10 in the form of a transparent and permeable polyurethane film.
- a front face of the film 10 (the lower face as viewed in Fig 2) is coated with an adhesive layer 12 which may be of any adhesive material suitable for medical or veterinary use; in this embodiment the material is a pressure-sensitive solvent-based acrylic compound.
- the adhesive material of the layer 12 and the polyurethane carrier sheet 10 may comprise a bacteriostatic silver compound such as a soluble glass containing silver orthophosphate.
- the layer 12 is covered by a cover sheet 14 which is a transparent polymer sheet held in place by the adhesive layer 12.
- the right edge of the cover sheet 14 (as viewed in Fig 2) is provided on its outer edge with a holding portion 14a which is an extension of the laminate, releasably connected to the carrier sheet 10.
- the cover sheet 14 is also provided with a pull tab 15 having a free-standing extension flap 15a.
- the holding portion 14a extends along a substantially central portion of the edge of the dressing 1. The holding portion 14a may thus be held at the central portion of this edge to facilitate handling of the dressing 1 and removal of the cover sheet 14.
- the holding portion 14a extends along the entire length of the edge of the dressing 1.
- the pull tab 15 extends across the entire width of the dressing 1 adjacent to the holding portion 14a.
- a rear face of the carrier sheet 10 (the upper face as viewed in Fig 2) is covered by a backing sheet 16 which adheres to the sheet 10 with an adhesiveness which is lower than that between the sheet 10 and the layer 12.
- the relatively lower tack between the rear face of the carrier sheet 10 and the backing sheet 16 ensures that when the dressing is applied, with the cover sheet 14 removed, from the front face of the sheet 10, to a surface of a patient's body and the backing sheet 16 is pulled, the backing sheet 16 separates from the sheet 10 while the relatively higher tack of the adhesive in the layer 12 continues to hold the carrier sheet 10 on to the body tissue of the patient.
- the backing sheet 16 is of a transparent polymer film, but other materials such as siliconised paper may alternatively be used for the backing sheet.
- the laminate of the cover sheet 14, the carrier sheet 10 and the backing sheet 16 as described above is available in manufactured strip form from, for example, the Rexham division of Bowater pic.
- the backing sheet tab 2 is an extension of the backing sheet 16 and extends from the backing sheet away from the carrier sheet 10. The backing sheet tab 2 extends substantially along one edge of the dressing 1 opposite the edge provided with the holding portion 14a.
- a score line 20 is formed through the cover sheet 14 adjacent and parallel to the edge of the dressing 1 between the holding tab 14a and the pull tab 15 (avoiding the pull tab extension flap 15a) .
- a line of perforations 21 is formed completely through the dressing 1 below the score line 20 from the same (lower) face of the dressing 1 as the score line 20 is formed. It is to be noted that the relative thicknesses of the various layers shown in the accompanying drawings are not necessarily to scale.
- the dressing 1 is supplied sterile in a sealed pouch (not shown) .
- the pouch is opened and the dressing 1 is removed from the pouch.
- the dressing is grasped by the holding portion 14a, and bent around the score line 20, which raises an adjacent edge of the main portion of the cover sheet 14 under the tab 15.
- the extension flap 15a is gripped by the user who can then peel the cover sheet 14 away from the adhesive layer 12 while holding the tab 14a on the opposite edge.
- the dressing 1 is then applied over the wound or other application site and pressed into place on the body tissue around the wound.
- the backing sheet 16 maintains the carrier sheet 10 in a dimensionally stable and readily handled condition, allowing the dressing to be secured to the body tissue around the wound or other application site without creasing or stretching of the carrier sheet 10.
- the backing sheet tab 2 is gripped by the user and is used to peel the backing sheet 16 away from the carrier sheet 10.
- the holding portion 14a is then removed from the film 10 by tearing along the perforations 21 after application of the main portion of the dressing 1 to the patient, the overlying edge of the carrier sheet 10 subsequently being smoothed down onto the body tissue of the patient.
- the carrier sheet 10 conforms well to the underlying tissue surface because the dressing 1 is flexible in two directions, ie length and width.
- the act of peeling the cover sheet 14 away from the carrier sheet 10 automatically takes the user's hands away from the face of the dressing 1 which will be applied to the patient's tissue, thus avoiding potentially contaminating contact to the wound.
- this edge of the dressing 1 could be cut off with scissors after application of the main portion of the dressing 1 to the patient.
- the dressing 1 may be readily manufactured. It is known to make film dressing material in bulk by laminating polyurethane film with adhesive and release layers. A dressing of the present invention can be made by removing a strip of the carrier sheet 10, adhesive layer 12 and cover sheet 14 along one edge of the dressing 1 to form the backing sheet tab 2, cutting the score line 20 and perforations 21 (for example using a rotary knife) and cutting the resulting strip across its width at suitable intervals to form individual dressings.
- An example of a bulk film dressing material consists of a lamination of:-
- PUf polyurethane film
- PSA pressure sensitive adhesive
- the PUf polyurethane film
- a silver-releasing product for example, a bacteriostat.
- a grid pattern may be printed onto the backing sheet 16 for monitoring wound size. After application of the carrier sheet 10 but prior to removal of the backing sheet 16, the outline of the wound can be traced onto the backing sheet. The area of the wound can subsequently be calculated from the outline on the grid, which is also suitable to be retained as a record as it is not contaminated by contact with the wound, having been spaced from the wound by the intervening polyurethane carrier sheet 10.
- Instructions for use of the dressing can be printed on the tabs 2, 14a and 15, as can advertisements and/or other messages.
- Islands of alginate or other absorbent materials can be pre-located in the centre of the dressing 1 as an aid to healing.
- the embodiments shown in Fig 3 , Fig 4 and Fig 5 are generally similar to that shown in Fig 1 and Fig 2.
- the layers of the laminate forming the dressing are shown separated although, in practice, adjacent layers are in contact.
- the backing sheet tab 2 is extended by a distance x away from the carrier sheet 10 with respect to the previously described embodiment. Increasing the distance that the backing sheet tab 2 extends away from the carrier sheet 10 may permit the user to bend the tab 2 towards the body of the carrier sheet 10 before beginning to peel the backing sheet 16 from the carrier sheet 10. This may make the backing sheet 16 easier to peel away without lifting the carrier sheet 10 from the surface to which it has been applied.
- the backing sheet tab 2 is formed from a tab member bend around, and secured to, an extension 16a of the backing sheet 16.
- the tab 2 may be provided by a piece of tape, for example, a polypropylene tape which may be self adhesive for attachment to the backing sheet extension 16a.
- the backing sheet tab 2 is attached to a surface of the backing sheet extension 16a by means of a layer of adhesive 3.
- the tab 2 may be provided in the form of a tape, for example, of polypropylene.
- the invention may be utilised as a transdermal medicament delivery system, for example as nicotine supply patches, or, as a non-medical application in the electronics industry.
- a transdermal medicament delivery system for example as nicotine supply patches, or, as a non-medical application in the electronics industry.
- - the dressing is easy to apply; - the dressing is protected against stretching during application; - the dressing is protected against creasing during application; - the dressing is not touched by the user during application, reducing problems of contamination; - the amount of waste material is reduced; - the dressing conforms well to uneven surfaces as it is flexible in two directions, ie length and width; - manufacture is simple and a wide range of sizes can readily be produced; for example, the depth of the score line once set provides accurately repeatable performance; - the whole of the dressing is transparent thus allowing the user to see exactly where it is being applied.
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Materials For Medical Uses (AREA)
Abstract
There is provided a laminate suitable for use as a wound dressing or as a transdermal medicament delivery system. The laminate is comprised of a carrier sheet sandwiched between a removable cover sheet and a removable backing sheet. The laminate has a cover sheet tab and a backing sheet tab, both tabs extending away from the carrier sheet. The laminate also comprises a holding portion. The holding portion and the two tabs facilitate application of the carrier sheet, which is normally in polyurethane film, to a surface of the patient and avoids stretching or wrinkling the carrier sheet. The carrier sheet will normally comprise a therapeutic agent, such as a bacteriostat and may be provided with an adhesive island to cover the wound.
Description
"SELF-ADHESIVE LAMINATE"
This invention relates to a laminate, and relates particularly but not exclusively to a dressing which is self-adherent to body surfaces around a wound.
In recent years, laminates for use as wound dressings have become available which are based on plastics films, commonly polyurethane films. The film may contain or act as a carrier for substances which act as bacteriostats or promote healing, for example, silver salts or alginates.
Film dressings of this nature have considerable advantages. Firstly, they can readily be produced in transparent form and thus allow the condition of a wound to be monitored without removing the dressing. Secondly, they can be produced in micro-porous forms which allow movement of water vapour to the exterior of the dressing and movement of air to the interior of the dressing while preventing movement of bacteria through the dressing; this is of particular benefit in treating exuding wounds such as burns.
To date, a disadvantage associated with known film
dressings has been that they can be difficult to apply to a wound. It is usual for a film dressing to have an adhesive layer for application to the skin of a user, the adhesive layer being initially covered by a release paper. Once the release paper is removed from the adhesive layer, the film is delicate and difficult to handle. Stretching of the film can destroy its barrier integrity, whilst a lack of tension during application can lead to wrinkling. For these reasons, most film dressings currently used are provided with a stiffening edge or frame on the outer face, which stiffening must be removed after the dressing has been applied. Known arrangements of dressings can, however, be undesirably complex to apply to a wound or other desired area.
According to a first aspect, the present invention provides a laminate having an associated holding portion, the laminate comprising a carrier sheet sandwiched between a removable cover sheet and a removable backing sheet, the laminate further comprising a cover sheet tab attached to the cover sheet and extending away from the carrier sheet, a backing sheet tab attached to the backing sheet and extending away from the carrier sheet and wherein the holding portion is releasably connected to the carrier sheet and is positioned so that it extends along a substantially central portion of one edge of the laminate.
The laminate may be provided as a dressing, for example, a wound dressing, or a dressing intended to release a medicament or therapeutic agent. In particular the laminate may be suitable as a medium for administration of an active ingredient in a controlled release manner over a relatively long period of time (eg several days to weeks) . The active ingredient will
normally be suitable for transdermal administration.
The cover sheet tab and backing sheet tab preferably facilitate removal of the cover sheet and backing sheet respectively from the laminate to facilitate application of the laminate to a wound or other area.
The holding portion is preferably attached to the laminate at a substantially central portion of the edge at which it is positioned and/or on each side of that substantially central portion.
Preferably, the holding portion extends substantially along one edge of the laminate. The holding portion may be attached to the carrier sheet by means of one or more lines of weakness which may be provided by perforations. The holding portion may be a continuation of the laminate.
The carrier sheet may be formed of a polymeric film material. Preferably, the carrier sheet is substantially porous to vapour and air but is substantially impermeable to particles of dirt or other contaminants, to micro-organisms and pathogens; the carrier sheet may be comprised wholly or partially of polyurethane or of compositions containing polyurethane.
The carrier sheet may comprise (for example be impregnated or coated with) a medicament or a therapeutic agent (for example, an antibiotic antiseptic, antibacterial, a bacteriostat) , a substance which is intended to promote healing (for example by stimulation of cell growth) or by an absorbent. The carrier sheet may be impregnated with a silver compound or an alginate. The carrier sheet may be provided with
an absorbent island, for example an alginate pad, which may cover the area to be treated.
A surface of the carrier sheet may be wholly or partially coated with a pressure sensitive adhesive to facilitate its attachment and retention to the area to be treated. The pressure sensitive adhesive may be a skin friendly acrylic adhesive.
The cover sheet tab may be provided by a tab secured to the cover sheet. The cover sheet tab is preferably positioned at the laminate adjacent to the holding portion. The cover sheet tab may extend across the width of the laminate and may be of a similar length to the holding portion.
Positioning the cover sheet tab adjacent to the holding portion may facilitate removal of the cover sheet from the laminate in use.
Preferably, the holding portion can be held by the user in one hand and the cover sheet tab is pulled away from the holding portion (thus removing the cover sheet from the laminate) by the user using his or her other hand.
The backing sheet tab may be provided as an extension of the backing sheet; it may extend beyond a periphery of the carrier layer of the laminate. The backing sheet tab may extend substantially along one edge of the laminate. Preferably, the backing sheet tab extends along a side of the laminate which is opposite the holding portion. The backing sheet tab may be formed of a flexible tape, for example a polypropylene tape; other self-adhesive pressure sensitive tapes are also suitable.
The backing sheet may be secured to the laminate by means of adhesion between the material of the backing sheet and the material of the carrier sheet; alternatively, it may be held on the carrier sheet by a separate adhesive material.
The backing sheet is preferably affixed to the rear face of the carrier sheet with an adhesiveness which is less than the adhesiveness between the front face of the carrier sheet and the cover sheet or, when the laminate has been affixed to a surface, between the carrier sheet and the surface (for example, where the laminate is a dressing the surface will be the wound to which it is applied) .
The backing sheet may have instructions for use of the laminate printed on it; it may have a pattern printed on it.
One or more of the carrier sheet, the cover sheet and the backing sheet may be translucent or substantially transparent; this may facilitate visual alignment of the laminate over a wound site when it is to be applied. Where the carrier sheet is substantially transparent, this may facilitate visual inspection of a wound covered by the laminate, when the laminate is in the form of a dressing, without necessitating removal of the dressing from the wound.
The cover sheet tab and/or the backing sheet tab may be coloured and/or have a pattern and/or indications printed on it to identify the tab region to a user.
According to a second aspect, the present invention provides a method of applying a laminate in accordance with the first aspect of the invention, in which:
a) a user grips the holding portion in one hand and removes the cover sheet from the laminate by holding the cover sheet tab and pulling the cover sheet tab away from the holding portion to detach the cover sheet from the carrier sheet; b) the exposed surface of the carrier sheet is then applied over a wound or other desired area using the holding portion to grip and position the dressing; c) the backing sheet is removed from the laminate by gripping the backing sheet tab and pulling the backing sheet tab away from the carrier layer to detach the backing sheet from the carrier sheet; and d) the holding portion is then removed from the positioned carrier sheet.
According to a third aspect, the present invention provides a method of manufacturing a laminate in accordance with the first aspect of the invention, said method comprising the following steps: a) providing a laminate having a carrier sheet sandwiched between a cover sheet and a backing sheet; b) forming a backing sheet tab; c) forming a cover sheet tab; and d) providing said carrier sheet with an associated holding portion.
Embodiments of the present invention will now be described, by way of example only, with reference to the accompanying drawings, of which:-
Fig. 1 is a plan view of a first embodiment of a laminate in the form of a wound dressing embodying the present invention, prior to use of the
dressing; Fig. 2 is a cross-section of Fig. 1; Fig. 3 is a cross-section of a second embodiment of a laminate in the form of a wound dressing embodying the present invention; Fig. 4 is a cross-section of a third embodiment of a laminate in the form of a wound dressing embodying the present invention; and Fig. 5 is a cross-section of a fourth embodiment of a wound dressing embodying the present invention.
The laminate of the dressing 1 shown in Fig 1 comprises a carrier sheet 10 in the form of a transparent and permeable polyurethane film. A front face of the film 10 (the lower face as viewed in Fig 2) is coated with an adhesive layer 12 which may be of any adhesive material suitable for medical or veterinary use; in this embodiment the material is a pressure-sensitive solvent-based acrylic compound. The adhesive material of the layer 12 and the polyurethane carrier sheet 10 may comprise a bacteriostatic silver compound such as a soluble glass containing silver orthophosphate. The layer 12 is covered by a cover sheet 14 which is a transparent polymer sheet held in place by the adhesive layer 12.
The right edge of the cover sheet 14 (as viewed in Fig 2) is provided on its outer edge with a holding portion 14a which is an extension of the laminate, releasably connected to the carrier sheet 10. Immediately in from the holding portion 14a, the cover sheet 14 is also provided with a pull tab 15 having a free-standing extension flap 15a. The holding portion 14a extends along a substantially central portion of the edge of the dressing 1. The holding portion 14a may thus be
held at the central portion of this edge to facilitate handling of the dressing 1 and removal of the cover sheet 14. In this embodiment, the holding portion 14a extends along the entire length of the edge of the dressing 1. The pull tab 15 extends across the entire width of the dressing 1 adjacent to the holding portion 14a.
A rear face of the carrier sheet 10 (the upper face as viewed in Fig 2) is covered by a backing sheet 16 which adheres to the sheet 10 with an adhesiveness which is lower than that between the sheet 10 and the layer 12. The relatively lower tack between the rear face of the carrier sheet 10 and the backing sheet 16 ensures that when the dressing is applied, with the cover sheet 14 removed, from the front face of the sheet 10, to a surface of a patient's body and the backing sheet 16 is pulled, the backing sheet 16 separates from the sheet 10 while the relatively higher tack of the adhesive in the layer 12 continues to hold the carrier sheet 10 on to the body tissue of the patient. The backing sheet 16 is of a transparent polymer film, but other materials such as siliconised paper may alternatively be used for the backing sheet.
The laminate of the cover sheet 14, the carrier sheet 10 and the backing sheet 16 as described above is available in manufactured strip form from, for example, the Rexham division of Bowater pic.
One edge of the dressing 1 (the left edge as viewed in Fig 2) is cut away through the cover sheet 14, the adhesive layer 12 and the carrier sheet 10, but leaving the backing sheet 16 intact across its original width. This partially cut-away edge of the dressing 1 forms a backing sheet tab 2. The backing sheet tab 2 is an
extension of the backing sheet 16 and extends from the backing sheet away from the carrier sheet 10. The backing sheet tab 2 extends substantially along one edge of the dressing 1 opposite the edge provided with the holding portion 14a.
A score line 20 is formed through the cover sheet 14 adjacent and parallel to the edge of the dressing 1 between the holding tab 14a and the pull tab 15 (avoiding the pull tab extension flap 15a) . A line of perforations 21 is formed completely through the dressing 1 below the score line 20 from the same (lower) face of the dressing 1 as the score line 20 is formed. It is to be noted that the relative thicknesses of the various layers shown in the accompanying drawings are not necessarily to scale.
In use, the dressing 1 is supplied sterile in a sealed pouch (not shown) . At the time and place of use of the dressing 1, the pouch is opened and the dressing 1 is removed from the pouch. The dressing is grasped by the holding portion 14a, and bent around the score line 20, which raises an adjacent edge of the main portion of the cover sheet 14 under the tab 15. The extension flap 15a is gripped by the user who can then peel the cover sheet 14 away from the adhesive layer 12 while holding the tab 14a on the opposite edge.
Once the cover sheet 14 has been removed, the dressing 1 is then applied over the wound or other application site and pressed into place on the body tissue around the wound. During this operation, the backing sheet 16 maintains the carrier sheet 10 in a dimensionally stable and readily handled condition, allowing the dressing to be secured to the body tissue around the wound or other application site without creasing or
stretching of the carrier sheet 10.
Thereafter, the backing sheet tab 2 is gripped by the user and is used to peel the backing sheet 16 away from the carrier sheet 10.
The holding portion 14a is then removed from the film 10 by tearing along the perforations 21 after application of the main portion of the dressing 1 to the patient, the overlying edge of the carrier sheet 10 subsequently being smoothed down onto the body tissue of the patient.
The carrier sheet 10 conforms well to the underlying tissue surface because the dressing 1 is flexible in two directions, ie length and width. The act of peeling the cover sheet 14 away from the carrier sheet 10 automatically takes the user's hands away from the face of the dressing 1 which will be applied to the patient's tissue, thus avoiding potentially contaminating contact to the wound. As an alternative to removing the holding portion 14a by tearing along the perforations 21, this edge of the dressing 1 could be cut off with scissors after application of the main portion of the dressing 1 to the patient.
The dressing 1 may be readily manufactured. It is known to make film dressing material in bulk by laminating polyurethane film with adhesive and release layers. A dressing of the present invention can be made by removing a strip of the carrier sheet 10, adhesive layer 12 and cover sheet 14 along one edge of the dressing 1 to form the backing sheet tab 2, cutting the score line 20 and perforations 21 (for example using a rotary knife) and cutting the resulting strip across its width at suitable intervals to form
individual dressings.
An example of a bulk film dressing material consists of a lamination of:-
sPETl/PUf/PSA/sPET2
where:- sPETl and sPET2 = siliconised polyethylene terephthalate having different silicone linearisations;
PUf = polyurethane film; PSA = pressure sensitive adhesive.
The PUf (polyurethane film) may be impregnated with a silver-releasing product, for example, a bacteriostat.
A grid pattern (not illustrated) may be printed onto the backing sheet 16 for monitoring wound size. After application of the carrier sheet 10 but prior to removal of the backing sheet 16, the outline of the wound can be traced onto the backing sheet. The area of the wound can subsequently be calculated from the outline on the grid, which is also suitable to be retained as a record as it is not contaminated by contact with the wound, having been spaced from the wound by the intervening polyurethane carrier sheet 10.
Instructions for use of the dressing can be printed on the tabs 2, 14a and 15, as can advertisements and/or other messages.
Islands of alginate or other absorbent materials can be pre-located in the centre of the dressing 1 as an aid to healing.
The embodiments shown in Fig 3 , Fig 4 and Fig 5 are generally similar to that shown in Fig 1 and Fig 2. For clarity, the layers of the laminate forming the dressing are shown separated although, in practice, adjacent layers are in contact.
In the embodiment of Fig 3, the backing sheet tab 2 is extended by a distance x away from the carrier sheet 10 with respect to the previously described embodiment. Increasing the distance that the backing sheet tab 2 extends away from the carrier sheet 10 may permit the user to bend the tab 2 towards the body of the carrier sheet 10 before beginning to peel the backing sheet 16 from the carrier sheet 10. This may make the backing sheet 16 easier to peel away without lifting the carrier sheet 10 from the surface to which it has been applied.
In the embodiment of Fig 4, the backing sheet tab 2 is formed from a tab member bend around, and secured to, an extension 16a of the backing sheet 16. In this embodiment, the tab 2 may be provided by a piece of tape, for example, a polypropylene tape which may be self adhesive for attachment to the backing sheet extension 16a.
In the embodiment of Fig 5, the backing sheet tab 2 is attached to a surface of the backing sheet extension 16a by means of a layer of adhesive 3. The tab 2 may be provided in the form of a tape, for example, of polypropylene.
As an alternative to a wound dressing, the invention may be utilised as a transdermal medicament delivery system, for example as nicotine supply patches, or, as a non-medical application in the electronics industry.
The above described embodiments of the present invention provide a dressing having a number of advantages:
- the dressing is easy to apply; - the dressing is protected against stretching during application; - the dressing is protected against creasing during application; - the dressing is not touched by the user during application, reducing problems of contamination; - the amount of waste material is reduced; - the dressing conforms well to uneven surfaces as it is flexible in two directions, ie length and width; - manufacture is simple and a wide range of sizes can readily be produced; for example, the depth of the score line once set provides accurately repeatable performance; - the whole of the dressing is transparent thus allowing the user to see exactly where it is being applied.
Claims
1. A laminate comprising a carrier sheet sandwiched between a removable cover sheet and a removable backing sheet, wherein a cover sheet tab is attached to the cover sheet and extends away from said carrier sheet, wherein a backing sheet tab is attached to said backing sheet and extends away from said carrier sheet, and wherein said laminate comprises an associated holding portion releasably connected to the carrier sheet and positioned so that it extends along a substantially central portion of one edge of said laminate.
2. A laminate as claimed in Claim 1 wherein the holding portion extends substantially along one edge of the laminate.
3. A laminate as claimed in either one of Claims 1 and 2 having perforations between said holding portion and said carrier sheet to facilitate removal of said holding portion.
4. A laminate as claimed in any one of Claims 1 to 3 wherein said carrier sheet is formed of a polymeric film material.
5. A laminate as claimed in any one of Claims 1 to 4 wherein said carrier sheet comprises a medicament or a therapeutic agent.
6. A laminate as claimed in any one of Claims 1 to 5 wherein said carrier sheet is provided with an absorbent island.
7. A laminate as claimed in any one of Claims 1 to 6 wherein said cover sheet tab is adjacent said holding portion.
8. A laminate as claimed in any one of Claims 1 to 7 wherein said backing sheet tab is an extension of said backing sheet or is attached to an extension of said backing sheet.
9. A laminate as claimed in any one of Claims 1 to 8 wherein one or more of said carrier sheet, said cover sheet and said backing sheet is translucent or substantially transparent.
10. A laminate as claimed in any one of Claims 1 to 9 wherein said backing sheet is affixed to the carrier sheet with an adhesiveness which is less than the adhesiveness between the carrier sheet and the cover sheet.
11. A method of applying a laminate as claimed in any one of Claims 1 to 10, in which: a) a user grips the holding portion in one hand and removes the cover sheet from the laminate by holding the cover sheet tab and pulling the cover sheet tab away from the holding portion to detach the cover sheet from the carrier sheet; b) the exposed surface of the carrier sheet is then applied over a wound or other desired area using the holding portion to grip and position the dressing; c) the backing sheet is removed from the laminate by gripping the backing sheet tab and pulling the backing sheet tab away from the carrier layer to detach the backing sheet from the carrier sheet; and d) the holding portion is then removed from the positioned carrier sheet.
12. A method of manufacturing a laminate as claimed in any one of Claims 1 to 10, said method comprising the following steps: a) providing a laminate having a carrier sheet sandwiched between a cover sheet and a backing sheet; b) forming a backing sheet tab; c) forming a cover sheet tab; and d) providing said carrier sheet with an associated holding portion.
13. The use of a laminate as claimed in any one of Claims 1 to 10 as a wound dressing.
14. The use of a laminate as claimed in any one of Claims 1 to 10 as a transdermal medicament delivery system .
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9500716.7A GB9500716D0 (en) | 1995-01-14 | 1995-01-14 | Self adhesive laminate |
GB9500716 | 1995-01-14 | ||
PCT/GB1996/000055 WO1996021410A1 (en) | 1995-01-14 | 1996-01-12 | Self-adhesive laminate |
Publications (1)
Publication Number | Publication Date |
---|---|
EP0802777A1 true EP0802777A1 (en) | 1997-10-29 |
Family
ID=10768031
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP96900147A Ceased EP0802777A1 (en) | 1995-01-14 | 1996-01-12 | Self-adhesive laminate |
Country Status (6)
Country | Link |
---|---|
EP (1) | EP0802777A1 (en) |
JP (1) | JPH10511881A (en) |
AU (1) | AU4353296A (en) |
CA (1) | CA2210224A1 (en) |
GB (1) | GB9500716D0 (en) |
WO (1) | WO1996021410A1 (en) |
Families Citing this family (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE10056014A1 (en) * | 2000-11-11 | 2002-05-16 | Beiersdorf Ag | Laminated plaster with active substance, used as transdermal therapeutic system, has impermeable barrier layer on side away from skin and separable carrier layer with adhesive on side towards skin |
US7846141B2 (en) | 2002-09-03 | 2010-12-07 | Bluesky Medical Group Incorporated | Reduced pressure treatment system |
GB0224986D0 (en) | 2002-10-28 | 2002-12-04 | Smith & Nephew | Apparatus |
DE10312452B4 (en) * | 2003-03-20 | 2014-12-24 | Lohmann & Rauscher Gmbh & Co. Kg | Method for producing a wound care product |
IL156374A0 (en) * | 2003-06-10 | 2004-01-04 | Danenberg Holdings 2000 Ltd N | Method for removing a pigmented section of skin |
GB0325129D0 (en) | 2003-10-28 | 2003-12-03 | Smith & Nephew | Apparatus in situ |
CN101232858B (en) | 2005-08-01 | 2011-08-24 | 华克医药科技有限公司 | Eradication of pigmentation and scar tissue |
CN101257875A (en) | 2005-09-06 | 2008-09-03 | 泰科保健集团有限合伙公司 | Self contained wound dressing with micropump |
US7779625B2 (en) | 2006-05-11 | 2010-08-24 | Kalypto Medical, Inc. | Device and method for wound therapy |
CA2604623C (en) | 2006-09-28 | 2018-10-30 | Tyco Healthcare Group Lp | Portable wound therapy system |
GB0722820D0 (en) | 2007-11-21 | 2008-01-02 | Smith & Nephew | Vacuum assisted wound dressing |
US9061095B2 (en) | 2010-04-27 | 2015-06-23 | Smith & Nephew Plc | Wound dressing and method of use |
WO2012029127A1 (en) * | 2010-08-31 | 2012-03-08 | ニチバン株式会社 | Skin patch sheet, utilization of same, and method for applying skin patch sheet |
JP5384730B2 (en) * | 2010-08-31 | 2014-01-08 | ニチバン株式会社 | Patch sheet |
JP6208124B2 (en) | 2011-07-14 | 2017-10-04 | スミス アンド ネフュー ピーエルシーSmith & Nephew Public Limited Company | Wound dressing and method for producing the wound dressing |
EP3708196A1 (en) | 2012-03-12 | 2020-09-16 | Smith & Nephew PLC | Reduced pressure apparatus and methods |
US9427505B2 (en) | 2012-05-15 | 2016-08-30 | Smith & Nephew Plc | Negative pressure wound therapy apparatus |
HUE047600T2 (en) | 2012-05-23 | 2020-04-28 | Smith & Nephew | Apparatuses for negative pressure wound therapy |
ES2625709T3 (en) | 2012-08-01 | 2017-07-20 | Smith & Nephew Plc. | Wound dressing |
MX2015001520A (en) | 2012-08-01 | 2015-08-20 | Smith & Nephew | Wound dressing. |
AU2015370583B2 (en) | 2014-12-22 | 2020-08-20 | Smith & Nephew Plc | Negative pressure wound therapy apparatus and methods |
US20180092779A1 (en) * | 2015-04-24 | 2018-04-05 | Avery Dennison Corporation | Easy to apply dressings |
GB2555584B (en) | 2016-10-28 | 2020-05-27 | Smith & Nephew | Multi-layered wound dressing and method of manufacture |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8820563D0 (en) * | 1988-08-31 | 1988-09-28 | Britcair Ltd | Adhesive dressings |
FR2690617B1 (en) * | 1992-04-29 | 1994-06-24 | Cbh Textile | TRANSPARENT ADHESIVE DRESSING. |
GB9310185D0 (en) * | 1993-05-18 | 1993-06-30 | Giltech Ltd | Wound dressing |
FR2711056B1 (en) * | 1993-10-15 | 1996-01-19 | Hydrex Lab Sa | Absorbent adhesive dressing. |
-
1995
- 1995-01-14 GB GBGB9500716.7A patent/GB9500716D0/en active Pending
-
1996
- 1996-01-12 WO PCT/GB1996/000055 patent/WO1996021410A1/en not_active Application Discontinuation
- 1996-01-12 CA CA 2210224 patent/CA2210224A1/en not_active Abandoned
- 1996-01-12 AU AU43532/96A patent/AU4353296A/en not_active Abandoned
- 1996-01-12 EP EP96900147A patent/EP0802777A1/en not_active Ceased
- 1996-01-12 JP JP8521521A patent/JPH10511881A/en active Pending
Non-Patent Citations (1)
Title |
---|
See references of WO9621410A1 * |
Also Published As
Publication number | Publication date |
---|---|
WO1996021410A1 (en) | 1996-07-18 |
GB9500716D0 (en) | 1995-03-08 |
AU4353296A (en) | 1996-07-31 |
CA2210224A1 (en) | 1996-07-18 |
JPH10511881A (en) | 1998-11-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0699127B1 (en) | Self-adhesive laminate | |
WO1996021410A1 (en) | Self-adhesive laminate | |
JP5080384B2 (en) | Packaged medical adhesive composite | |
US5489262A (en) | Transparent hydrogel wound dressing with release tab | |
AU616535B2 (en) | Adhesive sheet | |
US5000172A (en) | Dressing system with reference marks | |
US4600001A (en) | Combined wound dressing and delivery means composite | |
US5709651A (en) | Adhesive dressing | |
US6350339B1 (en) | Non-stretching wound dressing and method for making same | |
US5035687A (en) | Adhesive dressings | |
EP0120570B1 (en) | Wound dressing | |
EP0630629B1 (en) | Hydrogel wound dressing product | |
US6884920B2 (en) | Hydrocolloid window catheter dressing and a method for making and using the same | |
EP0434258A2 (en) | Adhesive dressing assemblies and methods of dressing | |
JPH01280458A (en) | One-stage dressing feed-out system | |
JP2831394B2 (en) | Adhesive dressing, its manufacturing method and application | |
AU1391197A (en) | Wound dressing | |
GB2131299A (en) | Adhesive film dressing | |
GB2128479A (en) | Application of surgical dressings | |
WO1990001915A2 (en) | Adhesive dressings | |
US20050075595A1 (en) | Adhesive dressings | |
CA1222671A (en) | Dressings | |
EP0675702B1 (en) | Adhesive dressing | |
GB2316618A (en) | Device for dispensing pieces of adhesive strip | |
JPH0687873B2 (en) | Adhesive film dressing |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 19970804 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE |
|
17Q | First examination report despatched |
Effective date: 19980401 |
|
GRAG | Despatch of communication of intention to grant |
Free format text: ORIGINAL CODE: EPIDOS AGRA |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION HAS BEEN REFUSED |
|
18R | Application refused |
Effective date: 20011231 |